Published in J Biol Chem on September 22, 2010
LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. Cell (2012) 2.79
How lamina-associated polypeptide 1 (LAP1) activates Torsin. Elife (2014) 1.11
Molecular pathways in dystonia. Neurobiol Dis (2010) 1.02
The mechanism of Torsin ATPase activation. Proc Natl Acad Sci U S A (2014) 0.96
Torsin ATPases: structural insights and functional perspectives. Curr Opin Cell Biol (2016) 0.91
Torsins: not your typical AAA+ ATPases. Crit Rev Biochem Mol Biol (2015) 0.91
The nuclear envelope localization of DYT1 dystonia torsinA-ΔE requires the SUN1 LINC complex component. BMC Cell Biol (2011) 0.90
Access of torsinA to the inner nuclear membrane is activity dependent and regulated in the endoplasmic reticulum. J Cell Sci (2015) 0.87
Untethering the nuclear envelope and cytoskeleton: biologically distinct dystonias arising from a common cellular dysfunction. Int J Cell Biol (2012) 0.87
TorsinA controls TAN line assembly and the retrograde flow of dorsal perinuclear actin cables during rearward nuclear movement. J Cell Biol (2017) 0.85
Structures of TorsinA and its disease-mutant complexed with an activator reveal the molecular basis for primary dystonia. Elife (2016) 0.83
LINCing defective nuclear-cytoskeletal coupling and DYT1 dystonia. Cell Mol Bioeng (2016) 0.82
Site-specific Proteolysis Mobilizes TorsinA from the Membrane of the Endoplasmic Reticulum (ER) in Response to ER Stress and B Cell Stimulation. J Biol Chem (2016) 0.80
The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia. J Biol Chem (2014) 0.79
Current Gaps in the Understanding of the Subcellular Distribution of Exogenous and Endogenous Protein TorsinA. Tremor Other Hyperkinet Mov (N Y) (2014) 0.78
DYT1 knock-in mice are not sensitized against mitochondrial complex-II inhibition. PLoS One (2012) 0.78
Torsin ATPases: Harnessing Dynamic Instability for Function. Front Mol Biosci (2017) 0.77
Lamina Associated Polypeptide 1 (LAP1) Interactome and Its Functional Features. Membranes (Basel) (2016) 0.77
Disruption of Protein Processing in the Endoplasmic Reticulum of DYT1 Knock-in Mice Implicates Novel Pathways in Dystonia Pathogenesis. J Neurosci (2016) 0.75
A novel high-throughput yeast genetic screen for factors modifying protein levels of the Early-Onset Torsion Dystonia-associated variant torsinAΔE. Dis Model Mech (2017) 0.75
Dynamic functional assembly of the Torsin AAA+ ATPase and its modulation by LAP1. Mol Biol Cell (2017) 0.75
AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res (1999) 11.30
AAA+ proteins: have engine, will work. Nat Rev Mol Cell Biol (2005) 7.73
Oxidized redox state of glutathione in the endoplasmic reticulum. Science (1992) 6.91
Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol Cell (2000) 6.39
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet (1997) 5.39
Evolutionary relationships and structural mechanisms of AAA+ proteins. Annu Rev Biophys Biomol Struct (2006) 4.74
AAA proteins. Lords of the ring. J Cell Biol (2000) 3.89
Integral membrane proteins of the nuclear envelope interact with lamins and chromosomes, and binding is modulated by mitotic phosphorylation. Cell (1993) 3.77
Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron (2005) 3.75
The pathophysiological basis of dystonias. Nat Rev Neurosci (2008) 3.46
The structure of ClpB: a molecular chaperone that rescues proteins from an aggregated state. Cell (2003) 2.89
Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J Neurosci (2005) 2.50
Extracellular thiols and thiol/disulfide redox in metabolism. Annu Rev Nutr (2004) 2.41
ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome. Mol Cell (2006) 2.26
Roles of individual domains and conserved motifs of the AAA+ chaperone ClpB in oligomerization, ATP hydrolysis, and chaperone activity. J Biol Chem (2003) 2.26
Hsp104 and ClpB: protein disaggregating machines. Trends Biochem Sci (2008) 2.23
Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc Natl Acad Sci U S A (2004) 2.19
TorsinA in the nuclear envelope. Proc Natl Acad Sci U S A (2004) 2.06
Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet (2000) 1.90
The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. J Cell Biol (2005) 1.89
Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations. J Biol Chem (2000) 1.81
TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton. J Cell Sci (2008) 1.80
Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A (2004) 1.78
Glutathione directly reduces an oxidoreductase in the endoplasmic reticulum of mammalian cells. J Biol Chem (2004) 1.77
TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J Neurochem (2002) 1.77
Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc Natl Acad Sci U S A (2007) 1.73
Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia. J Neurosci (2004) 1.71
A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. Proc Natl Acad Sci U S A (2010) 1.51
TorsinA: movement at many levels. Neuron (2001) 1.49
LULL1 retargets TorsinA to the nuclear envelope revealing an activity that is impaired by the DYT1 dystonia mutation. Mol Biol Cell (2009) 1.47
Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiol Dis (2005) 1.44
TorsinA in PC12 cells: localization in the endoplasmic reticulum and response to stress. J Neurosci Res (2003) 1.42
Dopamine release is impaired in a mouse model of DYT1 dystonia. J Neurochem (2007) 1.41
Microstructural white matter changes in primary torsion dystonia. Mov Disord (2008) 1.38
Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier. Hum Mol Genet (2006) 1.35
Characterization of human torsinA and its dystonia-associated mutant form. Biochem J (2003) 1.29
Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice. Exp Neurol (2008) 1.29
Interaction of torsinA with its major binding partners is impaired by the dystonia-associated DeltaGAG deletion. J Biol Chem (2009) 1.26
Dystonia-associated mutations cause premature degradation of torsinA protein and cell-type-specific mislocalization to the nuclear envelope. Hum Mol Genet (2008) 1.25
The torsin-family AAA+ protein OOC-5 contains a critical disulfide adjacent to Sensor-II that couples redox state to nucleotide binding. Mol Biol Cell (2008) 1.25
The dystonia-associated protein torsinA modulates synaptic vesicle recycling. J Biol Chem (2007) 1.23
Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics (2001) 1.18
Biosynthesis of the dystonia-associated AAA+ ATPase torsinA at the endoplasmic reticulum. Biochem J (2007) 1.14
The Caenorhabditis elegans polarity gene ooc-5 encodes a Torsin-related protein of the AAA ATPase superfamily. Development (2001) 1.12
Overexpression of torsinA in PC12 cells protects against toxicity. J Neurochem (2004) 1.08
Contributions of ATP, GTP, and redox state to nutritional stress activation of the Bacillus subtilis sigmaB transcription factor. J Bacteriol (2005) 1.08
Commentary: Dopaminergic dysfunction in DYT1 dystonia. Exp Neurol (2008) 1.06
Mitochondrial ATP-sensitive K+ channels are redox-sensitive pathways that control reactive oxygen species production. Free Radic Biol Med (2007) 1.06
TorsinA protects against oxidative stress in COS-1 and PC12 cells. Neurosci Lett (2003) 1.06
The TOR1A (DYT1) gene family and its role in early onset torsion dystonia. Genomics (1999) 1.05
Reversible redox control of plant vacuolar H+-ATPase activity is related to disulfide bridge formation in subunit E as well as subunit A. Plant J (2001) 1.02
Redox modulation of vascular tone: focus of potassium channel mechanisms of dilation. Arterioscler Thromb Vasc Biol (2005) 0.98
Molecular cloning of one isotype of human lamina-associated polypeptide 1s and a topological analysis using its deletion mutants. Biochem Biophys Res Commun (2002) 0.95
Neuroimaging in human dystonia. J Med Invest (2005) 0.93
Inhibition of N-linked glycosylation prevents inclusion formation by the dystonia-related mutant form of torsinA. Mol Cell Neurosci (2004) 0.91
ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol Cell (2002) 4.79
Gating of CFTR by the STAS domain of SLC26 transporters. Nat Cell Biol (2004) 3.43
Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J (2003) 3.35
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet (2013) 2.91
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol (2009) 2.70
Cooperative, ATP-dependent association of the nucleotide binding cassettes during the catalytic cycle of ATP-binding cassette transporters. J Biol Chem (2002) 2.64
Endoproteolytic activity of the proteasome. Science (2002) 2.56
Side chain and backbone contributions of Phe508 to CFTR folding. Nat Struct Mol Biol (2004) 2.43
ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome. Mol Cell (2006) 2.26
A molecular mechanism for aberrant CFTR-dependent HCO(3)(-) transport in cystic fibrosis. EMBO J (2002) 2.11
CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices. Nat Struct Mol Biol (2007) 1.98
Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation. Chem Biol (2008) 1.97
A protein sequence that can encode native structure by disfavoring alternate conformations. Nat Struct Biol (2002) 1.85
Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences. Cell (2012) 1.81
Coupling modes and stoichiometry of Cl-/HCO3- exchange by slc26a3 and slc26a6. J Gen Physiol (2006) 1.73
A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J Biol Chem (2005) 1.65
Slc26a6 regulates CFTR activity in vivo to determine pancreatic duct HCO3- secretion: relevance to cystic fibrosis. EMBO J (2006) 1.56
The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. J Biol Chem (2010) 1.55
MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis (2006) 1.54
Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy. Eur J Intern Med (2011) 1.48
Congenital chloride-losing diarrhea causing mutations in the STAS domain result in misfolding and mistrafficking of SLC26A3. J Biol Chem (2008) 1.43
Uncoupling retro-translocation and degradation in the ER-associated degradation of a soluble protein. EMBO J (2004) 1.38
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients. Inflamm Bowel Dis (2013) 1.31
Dynamic control of cystic fibrosis transmembrane conductance regulator Cl(-)/HCO3(-) selectivity by external Cl(-). J Biol Chem (2004) 1.28
The torsin-family AAA+ protein OOC-5 contains a critical disulfide adjacent to Sensor-II that couples redox state to nucleotide binding. Mol Biol Cell (2008) 1.25
Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator. J Biol Chem (2003) 1.23
IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway. J Clin Invest (2011) 1.18
Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening. J Comput Aided Mol Des (2010) 1.17
The primary folding defect and rescue of ΔF508 CFTR emerge during translation of the mutant domain. PLoS One (2010) 1.17
Conformational remodeling of proteasomal substrates by PA700, the 19 S regulatory complex of the 26 S proteasome. J Biol Chem (2002) 1.15
Building an understanding of cystic fibrosis on the foundation of ABC transporter structures. J Bioenerg Biomembr (2007) 1.14
NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR. EMBO J (2009) 1.12
Water and ligand entry in myoglobin: assessing the speed and extent of heme pocket hydration after CO photodissociation. Proc Natl Acad Sci U S A (2006) 1.07
Aggresome formation. Methods Mol Biol (2005) 1.06
The cystic fibrosis transmembrane conductance regulator interacts with and regulates the activity of the HCO3- salvage transporter human Na+-HCO3- cotransport isoform 3. J Biol Chem (2002) 1.06
Regulatory R region of the CFTR chloride channel is a dynamic integrator of phospho-dependent intra- and intermolecular interactions. Proc Natl Acad Sci U S A (2013) 1.06
Regulatory interaction between CFTR and the SLC26 transporters. Novartis Found Symp (2006) 1.04
Association of the organic cation transporter OCTN genes with Crohn's disease in the Spanish population. Eur J Hum Genet (2006) 0.96
Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm Bowel Dis (2005) 0.95
Nucleotide binding domain interactions during the mechanochemical reaction cycle of ATP-binding cassette transporters. J Bioenerg Biomembr (2005) 0.93
Mutations that change the position of the putative gamma-phosphate linker in the nucleotide binding domains of CFTR alter channel gating. J Biol Chem (2002) 0.91
IBD1 and IBD3 determine location of Crohn's disease in the Spanish population. Inflamm Bowel Dis (2004) 0.90
Insights into cytokine-receptor interactions from cytokine engineering. Annu Rev Immunol (2014) 0.87
Recognition and processing of misfolded proteins by PA700, the 19S regulatory complex of the 26S proteasome. Methods Mol Biol (2005) 0.87
Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations. J Bioenerg Biomembr (2010) 0.84
Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene. World J Gastroenterol (2006) 0.83
Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology. Am J Pathol (2010) 0.83
Alteration of CFTR transmembrane span integration by disease-causing mutations. Mol Biol Cell (2011) 0.82
The pH dependence of heme pocket hydration and ligand rebinding kinetics in photodissociated carbonmonoxymyoglobin. J Biol Chem (2008) 0.82
Optical detection of disordered water within a protein cavity. J Am Chem Soc (2009) 0.82
Assessment of protein folding/solubility in live cells. Methods Mol Biol (2003) 0.80
CFTR Folding Consortium: methods available for studies of CFTR folding and correction. Methods Mol Biol (2011) 0.79
The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia. J Biol Chem (2014) 0.79
Biochemical and biophysical approaches to probe CFTR structure. Methods Mol Biol (2011) 0.78
TDP-43 identified from a genome wide RNAi screen for SOD1 regulators. PLoS One (2012) 0.78
Development of CFTR Structure. Front Pharmacol (2012) 0.77
Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction. J Androl (2006) 0.77
Introduction to section IV: biophysical methods to approach CFTR structure. Methods Mol Biol (2011) 0.76
CFTR degradation and aggregation. Methods Mol Med (2002) 0.76
Strong protective effect of DR3 against ulcerative colitis in the Spanish population. Am J Gastroenterol (2007) 0.76
A screen to identify cellular modulators of soluble levels of an amyotrophic lateral sclerosis (ALS)-causing mutant SOD1. J Biomol Screen (2011) 0.76
Analysis of a non-synonymous single nucleotide polymorphism of the human diamine oxidase gene (ref. SNP ID: rs1049793) in patients with Crohn's disease. Scand J Gastroenterol (2009) 0.75
In vitro CFTR folding assays. Methods Mol Med (2002) 0.75